Next-Generation Sequencing Defines a Molecularly Confirmed ARPKD Core Within the Broader PKHD1-Associated Disease Spectrum
Genes · 2026
DOI: 10.3390/genes17020229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Paloma Lapunzina-Soler und 12 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Doctorado, Universidad de Navarra, 31009 Pamplona, Spain. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Recessive, Receptors, Cell Surface. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Autosomal recessive polycystic kidney disease (ARPKD) is a severe ciliopathy caused by biallelic pathogenic variants in PKHD1, characterized by variable renal and hepatobiliary involvement. The widespread use of next-generation sequencing (NGS) has revealed a large number of rare PKHD1 variants, creating major challenges in distinguishing molecularly confirmed ARPKD from a broader spectrum of PKHD1-associated disease.
Methods
We performed an integrated clinical and molecular analysis of 68 individuals referred for suspected ARPKD. Using phase-aware and family-informed ACMG classification, patients were stratified into three genetically defined groups: 40 with molecularly confirmed ARPKD (biallelic pathogenic, likely pathogenic or segregation-supported VUS-LP variants in trans), 10 with biallelic PKHD1 variants of uncertain pathogenicity, and 18 monoallelic carriers. Genotype–phenotype correlations were restricted to the molecularly confirmed ARPKD group.
Results
Among the 40 molecularly confirmed ARPKD patients, 17 (42.5%) carried two loss-of-function (LoF) alleles, 16 (40%) carried one LoF allele, and 7 (17.5%) carried only non-LoF alleles. A strong allele-dose effect was observed. Neonatal or infantile onset occurred in 88% of LoF/LoF patients, compared with 56% of LoF/non-LoF and 29% of non-LoF/non-LoF individuals (p < 0.001). Progression to renal replacement therapy occurred in 65%, 31%, and 0% of patients (p = 0.002). In contrast, hepatobiliary disease was highly prevalent across all genotype classes and showed no significant association with LoF burden.
Conclusions
Phase-aware and family-informed interpretation of PKHD1 variants distinguishes a molecularly confirmed ARPKD core from a broader PKHD1 variant spectrum. Within confirmed ARPKD, loss-of-function allele burden is the primary determinant of renal and perinatal severity, whereas hepatic disease is largely independent of truncating allele burden. These findings refine diagnosis, prognosis, and genetic counseling in the genomic era.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Escuela de Doctorado, Universidad de Navarra, 31009 Pamplona, Spain.
- Servicio de Nefrología de Adultos, Hospital Universitario La Paz, 28046 Madrid, Spain.
- Servicio de Nefrología Infantil, Hospital Universitario La Paz, 28046 Madrid, Spain.
- Servicio de Radiología, Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma, 28046 Madrid, Spain.
- Instituto de Genética Médica y Molecular, INGEMM, Hospital Universitario La Paz, 28046 Madrid, Spain.
- CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, 28046 Madrid, Spain.
ORCID-Profile: Amir Shabaka, Ramón Peces, Laura Espinosa-Román, Marta Melgosa, Jair Tenorio-Castaño, Pablo Lapunzina, Julián Nevado
Zitieren
APA
Lapunzina-Soler, P., Shabaka, A., Peces, R., Alonso, Á., Cuesta, E., Mena, R., Espinosa-Román, L., Melgosa, M., Fernández, G., Muñoz-GᵃPorrero, Y., Tenorio-Castaño, J., Lapunzina, P., & Nevado, J. (2026). Next-Generation Sequencing Defines a Molecularly Confirmed ARPKD Core Within the Broader PKHD1-Associated Disease Spectrum. Genes. https://doi.org/10.3390/genes17020229
Vancouver
Lapunzina-Soler P, Shabaka A, Peces R, Alonso Á, Cuesta E, Mena R, et al. Next-Generation Sequencing Defines a Molecularly Confirmed ARPKD Core Within the Broader PKHD1-Associated Disease Spectrum. Genes. 2026. doi:10.3390/genes17020229
BibTeX
@article{LapunzinaSoler2026,
author = {Lapunzina-Soler, Paloma and Shabaka, Amir and Peces, Ramón and Alonso, Ángel and Cuesta, Emilio and Mena, Rocío and Espinosa-Román, Laura and Melgosa, Marta and Fernández, Gema and Muñoz-GᵃPorrero, Yolanda and Tenorio-Castaño, Jair and Lapunzina, Pablo and Nevado, Julián},
title = {Next-Generation Sequencing Defines a Molecularly Confirmed ARPKD Core Within the Broader PKHD1-Associated Disease Spectrum},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17020229}
}
EUVIMED